(Q40908719)

PubMed publication ID

10619490

24 September 2017

title

Role of proliferation and apoptosis in net growth rates of human breast cancer cells (MCF-7) treated with oestradiol and/or tamoxifen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6726337&resulttype=core&format=json

12 May 2020

1 reference

P E Budtz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6726337&resulttype=core&format=json

12 May 2020

language of work or name

1 reference

1 October 1999

1 reference

PubMed publication ID

24 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6726337&resulttype=core&format=json

12 May 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6726337&resulttype=core&format=json

12 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6726337&resulttype=core&format=json

12 May 2020

page(s)

289-302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6726337&resulttype=core&format=json

Tamoxifen inhibits nitrobenzylthioinosine-sensitive equilibrative uridine transport in human MCF-7 breast cancer cells

12 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.1999.3250289.X

Tamoxifen induces TGF-beta 1 activity and apoptosis of human MCF-7 breast cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.1999.3250289.X

Synergistic induction of apoptosis in breast cancer cells by tamoxifen and calmodulin inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.1999.3250289.X

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.1999.3250289.X

Purification and characterization of an alpha 1-antichymotrypsin-like 66 kDa protein from the human breast cancer cell line, MCF-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.1999.3250289.X

Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.1999.3250289.X

Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.1999.3250289.X

Regulation of the secretion of proteins synthesized by the human breast cancer cell line, MCF-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.1999.3250289.X

Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2184.1999.3250289.X

Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.

21 January 2018

1 reference

12 December 2020

Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture

1 reference

12 December 2020

Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare

1 reference

12 December 2020

Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells

1 reference

12 December 2020

Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells

1 reference

12 December 2020

The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor

1 reference

12 December 2020

Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation

1 reference

12 December 2020

Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy.

1 reference

12 December 2020

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk

1 reference

12 December 2020

Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells

1 reference

12 December 2020

Interactions of antiestrogens with human breast cancer in long-term tissue culture

1 reference

12 December 2020

Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin

1 reference

12 December 2020

Endocrine treatment of breast cancer in women

1 reference

12 December 2020

Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro

1 reference

12 December 2020

Regulation of antitrypsin and antichymotrypsin synthesis by MCF-7 breast cancer cell sublines

1 reference

12 December 2020

Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice

1 reference

12 December 2020

DNA double labelling with IdUrd and CldUrd for spatial and temporal analysis of cell proliferation and DNA replication

1 reference

12 December 2020

Cell cycle analysis of estrogen stimulated growth of the human breast cancer cell line, MCF-7.

1 reference

12 December 2020

Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase

1 reference

12 December 2020

Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine

1 reference

12 December 2020

Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population

1 reference

12 December 2020

Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7.

1 reference

12 December 2020

Cell death: programmed, apoptosis, necrosis, or other?

1 reference

12 December 2020

Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7

1 reference

12 December 2020

Serum albumin as a modulator on growth of the human breast cancer cell line, MCF-7.

1 reference

12 December 2020

Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells

1 reference

12 December 2020

Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase

1 reference

12 December 2020

Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration

1 reference

12 December 2020

Tamoxifen in advanced breast cancer

1 reference

12 December 2020

Transcriptional control of thymidine kinase gene expression by estrogen and antiestrogens in MCF-7 human breast cancer cells

1 reference

12 December 2020

Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice

1 reference

12 December 2020

Human breast cancer in the athymic nude mouse: cytostatic effects of long-term antiestrogen therapy

1 reference

12 December 2020

MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage

1 reference

12 December 2020

Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle

1 reference

12 December 2020

Cell cycle synchronization induced by tamoxifen and 17 beta-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine

1 reference

12 December 2020

10.1046/J.1365-2184.1999.3250289.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6726337&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6726337&resulttype=core&format=json

12 May 2020

PubMed publication ID

10619490

1 reference